Christopher Peetz
Director; Director, CHIEF EXECUTIVE OFFICER · 11 filings · Latest: Oct 6, 2026
Arcutis Biotherapeutics, Inc.
Mirum Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jan 23, 2026 | Option Exercise | — | 12,500 | — | 176,233 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jan 22, 2026 | Sale | $93.33 | 7,098 | $662.4K | 163,733 | |
MIRM | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Jan 21, 2026 | Option Exercise | — | 12,797 | — | 170,831 | |
MIRM | CHRISTOPHER PEETZ | — | Aug 11, 2025 | Proposed Sale | $62.00 | 40,000 | $2.5M | — | |
MIRM | CHRISTOPHER PEETZ | — | Aug 7, 2025 | Proposed Sale | $55.25 | 40,000 | $2.2M | — | |
MIRM | CHRISTOPHER PEETZ | — | Mar 3, 2025 | Proposed Sale | $46.91 | 40,000 | $1.9M | — |
← Previous
Page 2 of 2